The frequency of cerebral microbleeds increases with CHADS 2 scores in stroke patients with non-valvular atrial fibrillation

T. J. Song, J. Kim, H. S. Lee, C. M. Nam, H. S. Nam, Jihoe Heo, Y. D. Kim

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Background and purpose: Cerebral microbleeds (CMBs) are extravasations of blood from lipohyalinized or amyloid angiopathic cerebral arterioles, and the presence and numbers of CMBs are significantly associated with the development of oral anticoagulation (OA)-related intracranial haemorrhage (ICH). The aim of this study was to investigate whether there is a difference in CMBs burden according to CHADS 2 scores or CHA 2 DS 2 -VASc scores in non-valvular atrial fibrillation (NVAF) patients. Methods: We included 550 ischaemic stroke patients who had NVAF and who had undergone brain magnetic resonance imaging (MRI) with gradient-recalled echo (GRE) T2 sequences from our prospective stroke registry between January 2005 and November 2011. We calculated CHADS 2 scores and CHA 2 DS 2 -VASc scores for all patients based on their underlying cardiovascular diseases. The presence, location and number of CMBs were assessed in each patient. We also investigated whether the CMBs were actually associated with the development of ICH during follow-up. Results: The mean patient age was 70.4 ± 10.5 years, and 324 (58.9%) patients were men. One-hundred and seventy-three patients (31.5%) had CMBs detected on GRE MRI. Higher CHADS 2 scores or CHA 2 DS 2 -VASc scores were strongly associated with the presence and number of CMBs. During follow-up of median 3.1 ± 1.6 years, the presence of CMBs was independently associated with the development of ICH, whilst the CHADS 2 scores or CHA 2 DS 2 -VASc scores were not. Conclusions: Considering the positive association between the presence of CMBs and OA-related ICH, our results suggest that the increase in ICH in high-risk groups during OA may be related to an increased burden of CMBs.

Original languageEnglish
Pages (from-to)502-508
Number of pages7
JournalEuropean Journal of Neurology
Volume20
Issue number3
DOIs
Publication statusPublished - 2013 Mar 1

Fingerprint

Atrial Fibrillation
Intracranial Hemorrhages
Stroke
Magnetic Resonance Imaging
Arterioles
Amyloid
Registries
Cardiovascular Diseases
Brain

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Song, T. J. ; Kim, J. ; Lee, H. S. ; Nam, C. M. ; Nam, H. S. ; Heo, Jihoe ; Kim, Y. D. / The frequency of cerebral microbleeds increases with CHADS 2 scores in stroke patients with non-valvular atrial fibrillation In: European Journal of Neurology. 2013 ; Vol. 20, No. 3. pp. 502-508.
@article{61b6479e0a2c40e79f63afd90fb337e6,
title = "The frequency of cerebral microbleeds increases with CHADS 2 scores in stroke patients with non-valvular atrial fibrillation",
abstract = "Background and purpose: Cerebral microbleeds (CMBs) are extravasations of blood from lipohyalinized or amyloid angiopathic cerebral arterioles, and the presence and numbers of CMBs are significantly associated with the development of oral anticoagulation (OA)-related intracranial haemorrhage (ICH). The aim of this study was to investigate whether there is a difference in CMBs burden according to CHADS 2 scores or CHA 2 DS 2 -VASc scores in non-valvular atrial fibrillation (NVAF) patients. Methods: We included 550 ischaemic stroke patients who had NVAF and who had undergone brain magnetic resonance imaging (MRI) with gradient-recalled echo (GRE) T2 sequences from our prospective stroke registry between January 2005 and November 2011. We calculated CHADS 2 scores and CHA 2 DS 2 -VASc scores for all patients based on their underlying cardiovascular diseases. The presence, location and number of CMBs were assessed in each patient. We also investigated whether the CMBs were actually associated with the development of ICH during follow-up. Results: The mean patient age was 70.4 ± 10.5 years, and 324 (58.9{\%}) patients were men. One-hundred and seventy-three patients (31.5{\%}) had CMBs detected on GRE MRI. Higher CHADS 2 scores or CHA 2 DS 2 -VASc scores were strongly associated with the presence and number of CMBs. During follow-up of median 3.1 ± 1.6 years, the presence of CMBs was independently associated with the development of ICH, whilst the CHADS 2 scores or CHA 2 DS 2 -VASc scores were not. Conclusions: Considering the positive association between the presence of CMBs and OA-related ICH, our results suggest that the increase in ICH in high-risk groups during OA may be related to an increased burden of CMBs.",
author = "Song, {T. J.} and J. Kim and Lee, {H. S.} and Nam, {C. M.} and Nam, {H. S.} and Jihoe Heo and Kim, {Y. D.}",
year = "2013",
month = "3",
day = "1",
doi = "10.1111/ene.12003",
language = "English",
volume = "20",
pages = "502--508",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",
number = "3",

}

The frequency of cerebral microbleeds increases with CHADS 2 scores in stroke patients with non-valvular atrial fibrillation . / Song, T. J.; Kim, J.; Lee, H. S.; Nam, C. M.; Nam, H. S.; Heo, Jihoe; Kim, Y. D.

In: European Journal of Neurology, Vol. 20, No. 3, 01.03.2013, p. 502-508.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The frequency of cerebral microbleeds increases with CHADS 2 scores in stroke patients with non-valvular atrial fibrillation

AU - Song, T. J.

AU - Kim, J.

AU - Lee, H. S.

AU - Nam, C. M.

AU - Nam, H. S.

AU - Heo, Jihoe

AU - Kim, Y. D.

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Background and purpose: Cerebral microbleeds (CMBs) are extravasations of blood from lipohyalinized or amyloid angiopathic cerebral arterioles, and the presence and numbers of CMBs are significantly associated with the development of oral anticoagulation (OA)-related intracranial haemorrhage (ICH). The aim of this study was to investigate whether there is a difference in CMBs burden according to CHADS 2 scores or CHA 2 DS 2 -VASc scores in non-valvular atrial fibrillation (NVAF) patients. Methods: We included 550 ischaemic stroke patients who had NVAF and who had undergone brain magnetic resonance imaging (MRI) with gradient-recalled echo (GRE) T2 sequences from our prospective stroke registry between January 2005 and November 2011. We calculated CHADS 2 scores and CHA 2 DS 2 -VASc scores for all patients based on their underlying cardiovascular diseases. The presence, location and number of CMBs were assessed in each patient. We also investigated whether the CMBs were actually associated with the development of ICH during follow-up. Results: The mean patient age was 70.4 ± 10.5 years, and 324 (58.9%) patients were men. One-hundred and seventy-three patients (31.5%) had CMBs detected on GRE MRI. Higher CHADS 2 scores or CHA 2 DS 2 -VASc scores were strongly associated with the presence and number of CMBs. During follow-up of median 3.1 ± 1.6 years, the presence of CMBs was independently associated with the development of ICH, whilst the CHADS 2 scores or CHA 2 DS 2 -VASc scores were not. Conclusions: Considering the positive association between the presence of CMBs and OA-related ICH, our results suggest that the increase in ICH in high-risk groups during OA may be related to an increased burden of CMBs.

AB - Background and purpose: Cerebral microbleeds (CMBs) are extravasations of blood from lipohyalinized or amyloid angiopathic cerebral arterioles, and the presence and numbers of CMBs are significantly associated with the development of oral anticoagulation (OA)-related intracranial haemorrhage (ICH). The aim of this study was to investigate whether there is a difference in CMBs burden according to CHADS 2 scores or CHA 2 DS 2 -VASc scores in non-valvular atrial fibrillation (NVAF) patients. Methods: We included 550 ischaemic stroke patients who had NVAF and who had undergone brain magnetic resonance imaging (MRI) with gradient-recalled echo (GRE) T2 sequences from our prospective stroke registry between January 2005 and November 2011. We calculated CHADS 2 scores and CHA 2 DS 2 -VASc scores for all patients based on their underlying cardiovascular diseases. The presence, location and number of CMBs were assessed in each patient. We also investigated whether the CMBs were actually associated with the development of ICH during follow-up. Results: The mean patient age was 70.4 ± 10.5 years, and 324 (58.9%) patients were men. One-hundred and seventy-three patients (31.5%) had CMBs detected on GRE MRI. Higher CHADS 2 scores or CHA 2 DS 2 -VASc scores were strongly associated with the presence and number of CMBs. During follow-up of median 3.1 ± 1.6 years, the presence of CMBs was independently associated with the development of ICH, whilst the CHADS 2 scores or CHA 2 DS 2 -VASc scores were not. Conclusions: Considering the positive association between the presence of CMBs and OA-related ICH, our results suggest that the increase in ICH in high-risk groups during OA may be related to an increased burden of CMBs.

UR - http://www.scopus.com/inward/record.url?scp=84873988693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873988693&partnerID=8YFLogxK

U2 - 10.1111/ene.12003

DO - 10.1111/ene.12003

M3 - Article

VL - 20

SP - 502

EP - 508

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 3

ER -